loader
Please Wait
Applying Filters...

Annual Sales of Ropinirole reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 4,771Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Haruropi

02 5Requip

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : Haruropi

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Haruropi

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 9

2019 Revenue in Millions : 1

Growth (%) : 800

blank

02

Brand Name : Haruropi

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Haruropi

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 26

2020 Revenue in Millions : 9

Growth (%) : 244

blank

03

Brand Name : Haruropi

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Haruropi

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 30

2021 Revenue in Millions : 26

Growth (%) : 16

blank

04

Brand Name : Haruropi

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Haruropi

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 30

2022 Revenue in Millions : 30

Growth (%) : 13

blank

05

Brand Name : Requip

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Requip

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 155

2014 Revenue in Millions : 132

Growth (%) : -15%

blank

06

Brand Name : Requip

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Requip

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : -12.80%

2013 Revenue in Millions :

Growth (%) :

blank

07

Brand Name : Requip

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Requip

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 144

2015 Revenue in Millions : 115

Growth (%) : 25

blank

08

Brand Name : Requip

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Requip

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 155

2016 Revenue in Millions : 164

Growth (%) : -5

blank

09

Brand Name : Requip

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Requip

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 113

2017 Revenue in Millions : 146

Growth (%) : -23%

blank

10

Brand Name : Haruropi

Ropinirole

arrow
FNCE 2024
Not Confirmed

Brand Name : Haruropi

arrow
FNCE 2024
Not Confirmed

Ropinirole

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 1

2018 Revenue in Millions : 0

Growth (%) : 0

blank